Regulations.gov document
Boehringer Ingelheim Pharmaceuticals, Inc. - Information re Request by Office of Drug…
Other · FDA-2006-O-0057 · posted Oct 12, 2012
Key facts
| Document ID | FDA-2006-O-0057-0051 |
|---|---|
| Title | Boehringer Ingelheim Pharmaceuticals, Inc. - Information re Request by Office of Drug Evaluation IV Division of Nonprescription Regulation Development July 20, 2012 |
| Document type | Other |
| Subtype | Submission of Information |
| Agency | FDA |
| Docket | FDA-2006-O-0057 |
| Posted | Oct 12, 2012 |
| Comment period opens | Oct 12, 2012 |
At a glance
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: